As a leader in data-driven medicine, SOPHiA GENETICS lends its expertise to support White House Cancer Moonshot BOSTON and LAUSANNE, Switzerland, June 2, 2023 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, announced today at ASCO that it has joined as a founding member of CancerX, a new … Read more
— The endowment will go on to provide for the acquisition of an autoclave for the Asociacion Mexicana de Ayuda a Ninos con Cancer de San Luis Potosi, A.C — BEVERLY HILLS, Calif., June 2, 2023 /PRNewswire/ — Dr. Kevin Sands, a world-renowned practitioner of cosmetic dentistry, today shared his recent donation to Asociacion Mexicana de … Read more
RUNHOOD’s groundbreaking line of modular power stations dependably fuels any home medical device with clean, quiet power WALNUT, Calif., June 2, 2023 /PRNewswire/ — With as many as one in ten people spending their days fatigued from sleep apnea, millions of restless Americans are turning to CPAP machines to get a good night’s sleep. But CPAPs … Read more
-Invivoscribe se asocia con Complete Genomics para desarrollar y comercializar pruebas de biomarcadores para oncología e investigación del cáncer SAN DIEGO y SAN JOSÉ, California, 2 de junio de 2023 /PRNewswire/ — Invivoscribe y Complete Genomics han anunciado hoy que se han asociado para desarrollar y comercializar pruebas de biomarcadores en las plataformas NGS de Complete … Read more
SAN DIEGO y SAN JOSÉ, California, 2 de junio de 2023 /PRNewswire/ — Invivoscribe y Complete Genomics anunciaron hoy que habían celebrado un acuerdo para desarrollar y comercializar pruebas de biomarcadores en las plataformas NGS de Complete Genomics. El territorio es mundial, y el campo es oncología e investigación del cáncer. En virtud de los … Read more
Preclinical data show IV administration of a next-generation gene therapy produced dose-dependent replacement of syntaxin-binding protein 1 (STXBP1) throughout the brain, with efficacy predictive of clinical relevance lasting at least 12 months post therapeutic intervention Data to be showcased in an oral presentation at Epilepsy Therapies & Diagnostics Development Symposium today THOUSAND OAKS, Calif., June … Read more
The Business Research Company’s flagship product, the Global Market Model is the world’s largest database of market forecasts. Forecasts for over 5000 markets are updated every six months on the basis of economic, geopolitical, and sector-specific factors. The current forecast for the medical equipment industry was made in December 2022. LONDON, June 2, 2023 /PRNewswire/ … Read more
An oral presentation titled “Phase 1/2 Study of DF1001, an Immune Modulating TriNKET® Targeting HER2, in Patients with Advanced Solid Tumors: Phase 1 DF1001 Monotherapy Dose Escalation Results” will be provided by Howard Safran, MD during the ASCO Developmental Therapeutics – Immunotherapy Session on June 4th. WALTHAM, Mass., June 2, 2023 /PRNewswire/ — Dragonfly Therapeutics, … Read more
VANCOUVER, BC, June 2, 2023 /PRNewswire/ – WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (“WELL” or the “Company”), a company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that a team from WELL Health including Hamed Shahbazi, Founder and CEO, will … Read more
HONG KONG, June 2, 2023 /PRNewswire/ — Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies’ long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization. Recently, 9 of Viva’s portfolio companies have achieved significant results and … Read more